
HPQ · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $55.30B | $53.56B | $53.72B | $62.91B | $63.46B | $56.64B | $58.76B | $58.47B |
| Cost of Revenue | $43.90B | $41.74B | $42.21B | $50.65B | $50.05B | $46.22B | $47.59B | $47.80B |
| Gross Profit | $11.39B | $11.82B | $11.51B | $12.26B | — | — | — | — |
| Research & Development | $1.60B | $1.64B | $1.58B | $1.65B | $1.85B | $1.48B | $1.50B | $1.40B |
| Selling, General & Administrative | $5.82B | $5.66B | $5.36B | $5.26B | $5.73B | $4.90B | $5.37B | $5.10B |
| Operating Expenses | $8.22B | $8.00B | $8.05B | $7.70B | $58.10B | $53.20B | $54.88B | $54.64B |
| Operating Income | $3.17B | $3.82B | $3.46B | $4.56B | $5.36B | $3.44B | $3.88B | $3.83B |
| Interest Expense | $430.00M | $452.00M | $548.00M | $359.00M | $254.00M | $239.00M | $242.00M | $312.00M |
| Other Income / (Expense) | -$506.00M | -$539.00M | -$519.00M | -$235.00M | $2.21B | -$231.00M | -$1.35B | -$818.00M |
| Income Before Taxes | $2.67B | $3.28B | $2.94B | $4.32B | $7.57B | $3.21B | $2.52B | $3.01B |
| Provision for Income Taxes | $139.00M | $504.00M | -$326.00M | $1.19B | $1.03B | $396.00M | -$629.00M | -$2.31B |
| Net Income | $2.53B | $2.77B | $3.26B | $3.13B | $6.54B | $2.81B | $3.15B | $5.33B |
| Basic EPS | $2.67 | $2.83 | $3.29 | $3.02 | $5.41 | $1.99 | $2.08 | $3.30 |
| Diluted EPS | $2.65 | $2.81 | $3.26 | $2.98 | $5.36 | $1.98 | $2.07 | $3.26 |
| Basic Shares Outstanding | 946.00M | 979.00M | 992.00M | 1.04B | 1.21B | 1.41B | 1.51B | 1.61B |
| Diluted Shares Outstanding | 953.00M | 989.00M | 1.00B | 1.05B | 1.22B | 1.42B | 1.52B | 1.63B |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Oct 2026 | $3.23 | $3.15 | $3.27 | 6 | ↑6 ↓0 |
| Oct 2027 | $3.07 | $2.75 | $3.36 | 6 | ↑5 ↓0 |
| Oct 2028 | $3.18 | $2.93 | $3.35 | 3 | ↑2 ↓0 |
| Oct 2029 | $3.28 | $3.28 | $3.28 | 1 | ↑1 ↓0 |